Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$68,737
+$34,270 QoQ
Shares Held
450
+80.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RESOURCES MANAGEMENT CORP /CT/ /ADV holds $58,736,749 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
85,694 | $21,564,038 | |
| 2 | JNJ |
Johnson & Johnson
|
57,899 | $14,704,609 | |
| 3 | LLY |
ELI LILLY & Co
|
6,910 | $8,288,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
58,507 | $7,518,149 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
20,373 | $2,573,924 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,375 | $1,577,347 | |
| 7 | AMGN |
Amgen Inc
|
3,432 | $1,242,795 | |
| 8 | PFE |
Pfizer Inc
|
39,710 | $956,216 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,737 | 450 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,467 | 250 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $32,060 | 250 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,252 | 250 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $27,870 | 250 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $24,327 | 250 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,755 | 250 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $26,615 | 250 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,182 | 250 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $40,388 | 400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $40,744 | 400 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $40,364 | 400 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $5 | 136 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $36,288 | 400 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $34,204 | 450 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $38,038 | 450 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $39,487 | 450 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $84,845 | 970 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $79,326 | 970 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $90,783 | 995 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $101,293 | 1,185 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $111,899 | 1,185 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $103,047 | 1,185 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $136,250 | 1,560 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $128,622 | 1,560 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||